<DOC>
	<DOC>NCT02616861</DOC>
	<brief_summary>Stage 1: To assess the safety, tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) effects of the IW-1973 Tablet administered orally to healthy volunteers, in fed and fasted states, in a single-dose crossover study. Stage 2: To assess the safety, tolerability, PK profile, and PD effects of a range of doses of IW-1973 Tablet administered orally to healthy subjects in a 21-day, multiple ascending-dose study with optional up-titration of dose level within cohort.</brief_summary>
	<brief_title>Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject is an ambulatory male or female between 18 and 55 years old at the Screening Visit Subject's body mass index score is &gt; 18.5 and &lt; 30.0 kg/m2 at the Screening Visit Women of childbearing potential must have a negative pregnancy test and must agree to use doublebarrier contraception Subject is in good health and has no clinically significant findings on a physical examination Other inclusion criteria per protocol History of any clinically significant medical condition Other exclusion criteria per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>